Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

362.95
Delayed Data
As of 4:00pm ET
 -0.29 / -0.08%
Today’s Change
325.35
Today|||52-Week Range
484.57
-1.13%
Year-to-Date

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 446.00, with a high estimate of 598.00 and a low estimate of 345.00. The median estimate represents a +22.88% increase from the last price of 362.95.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.13
Sales
$1.3B
Reporting Date
Feb 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.11%
 
 
 
 
 
 
Growthannually -3.68%
 
 
 
 
 
 

Sales

Growthquarterly 7.76%
 
 
 
 
 
 
Growthannually 20.27%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.